<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="pmc">PeerJ</journal-id>
      <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
      <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
      <journal-title-group>
        <journal-title>PeerJ</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2167-8359</issn>
      <publisher>
        <publisher-name>PeerJ Inc.</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">61</article-id>
      <article-id pub-id-type="doi">10.7717/peerj.61</article-id>
      <article-categories>
        <subj-group subj-group-type="categories">
          <subject>Cell Biology</subject>
          <subject>Neuroscience</subject>
          <subject>Psychiatry and Psychology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>MCH and apomorphine in combination enhance action potential firing of nucleus accumbens shell neurons <italic>in vitro</italic></article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <name>
            <surname>Hopf</surname>
            <given-names>F Woodward</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
          <email>woody@gallo.ucsf.edu</email>
        </contrib>
        <contrib id="author-2" contrib-type="author">
          <name>
            <surname>Seif</surname>
            <given-names>Taban</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-3" contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Shinjae</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-4" contrib-type="author">
          <name>
            <surname>Civelli</surname>
            <given-names>Olivier</given-names>
          </name>
          <xref ref-type="aff" rid="aff-3">3</xref>
        </contrib>
        <aff id="aff-1"><label>1</label><institution>Ernest Gallo Clinic and Research Center, Department of Neurology, University of California</institution>, <addr-line>San Francisco, Emeryville, CA</addr-line>, <country>USA</country></aff>
        <aff id="aff-2"><label>2</label><institution>Department of Molecular and Cell Biology, Helen Wills Neuroscience Institute, University of California</institution>, <addr-line>Berkeley</addr-line>, <country>USA</country></aff>
        <aff id="aff-3"><label>3</label><institution>Departments of Pharmacology and Developmental and Cell Biology, University of California</institution>, <addr-line>Irvine, CA</addr-line>, <country>USA</country></aff>
      </contrib-group>
      <contrib-group content-type="editors">
        <contrib id="editor-1" contrib-type="editor">
          <name>
            <surname>Hökfelt</surname>
            <given-names>Tomas</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2013-04-09">
        <day>9</day>
        <month>4</month>
        <year iso-8601-date="2013">2013</year>
      </pub-date>
      <volume>1</volume>
      <elocation-id>e61</elocation-id>
      <history>
        <date date-type="received" iso-8601-date="2012-12-07">
          <day>7</day>
          <month>12</month>
          <year iso-8601-date="2012">2012</year>
        </date>
        <date date-type="accepted" iso-8601-date="2013-03-12">
          <day>12</day>
          <month>3</month>
          <year iso-8601-date="2013">2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2013 Hopf et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Hopf et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://peerj.com/articles/61"/>
      <abstract>
        <p>The MCH and dopamine receptor systems have been shown to modulate a number of behaviors related to reward processing, addiction, and neuropsychiatric conditions such as schizophrenia and depression. In addition, MCH and dopamine receptors can interact in a positive manner, for example in the expression of cocaine self-administration. A recent report (<xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>) showed that the DA1/DA2 dopamine receptor activator apomorphine suppresses pre-pulse inhibition, a preclinical model for some aspects of schizophrenia. Importantly, MCH can enhance the effects of lower doses of apomorphine, suggesting that co-modulation of dopamine and MCH receptors might alleviate some symptoms of schizophrenia with a lower dose of dopamine receptor modulator and thus fewer potential side effects. Here, we investigated whether MCH and apomorphine could enhance action potential firing <italic>in vitro</italic> in the nucleus accumbens shell (NAshell), a region which has previously been shown to mediate some behavioral effects of MCH. Using whole-cell patch-clamp electrophysiology, we found that MCH, which has no effect on firing on its own, was able to increase NAshell firing when combined with a subthreshold dose of apomorphine. Further, this MCH/apomorphine increase in firing was prevented by an antagonist of either a DA1 or a DA2 receptor, suggesting that apomorphine acts through both receptor types to enhance NAshell firing. The MCH/apomorphine-mediated firing increase was also prevented by an MCH receptor antagonist or a PKA inhibitor. Taken together, our results suggest that MCH can interact with lower doses of apomorphine to enhance NAshell firing, and thus that MCH and apomorphine might interact <italic>in vivo</italic> within the NAshell to suppress pre-pulse inhibition.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Schizophrenia</kwd>
        <kwd>Nucleus accumbens shell</kwd>
        <kwd>MCH</kwd>
        <kwd>Dopamine receptor</kwd>
        <kwd>Apomorphine</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="fund-1">
          <funding-source>NIDA/NIH</funding-source>
          <award-id>DA024746 (OC, FWH)</award-id>
          <award-id>DA028065 (TS)</award-id>
        </award-group>
        <funding-statement>This work was supported by the NIDA/NIH DA024746 (OC, FWH) and NIDA/NIH DA028065 (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>In addition to regulation of feeding, the melanin-concentrating hormone (MCH) system is an important regulator of a number of behaviors related to reward processing, addiction and other neuropsychiatric conditions such as schizophrenia and depression (<xref ref-type="bibr" rid="ref-16">Georgescu et al., 2005</xref>; <xref ref-type="bibr" rid="ref-35">Nestler &amp; Carlezon, 2006</xref>; <xref ref-type="bibr" rid="ref-47">Shirayama &amp; Chaki, 2006</xref>; <xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-32">Morganstern et al., 2010</xref>; <xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>; <xref ref-type="bibr" rid="ref-33">Mul et al., 2011</xref>; <xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>; <xref ref-type="bibr" rid="ref-9">Chung et al., 2011b</xref>). The dopamine system also plays a key role in many addiction- and motivation-related behaviors and neuropsychiatric conditions (<xref ref-type="bibr" rid="ref-14">Di Ciano et al., 2001</xref>; <xref ref-type="bibr" rid="ref-12">Di Chiara, 2002</xref>; <xref ref-type="bibr" rid="ref-35">Nestler &amp; Carlezon, 2006</xref>; <xref ref-type="bibr" rid="ref-47">Shirayama &amp; Chaki, 2006</xref>; <xref ref-type="bibr" rid="ref-13">Di Ciano, 2008</xref>; <xref ref-type="bibr" rid="ref-54">Wise, 2008</xref>). Interestingly, dopamine receptors and MCH can interact positively in the regulation of some behaviors including in animal models of cocaine addiction and schizophrenia (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>), while antagonistic interactions are also observed (<xref ref-type="bibr" rid="ref-16">Georgescu et al., 2005</xref>, see also <xref ref-type="bibr" rid="ref-51">Tyhon et al., 2008</xref>).</p>
      <p>A recent study (<xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>) examined pre-pulse inhibition (PPI), where a startle response to an intense stimulus can be suppressed when a weak stimulus (the pre-pulse) immediately precedes the intense stimulus. The PPI is used as a measure of sensorimotor gating, and significant deficits in PPI are observed in patients with schizophrenia and some other neurological disorders, which may contribute to sensory overload and related symptoms (<xref ref-type="bibr" rid="ref-5">Braff, Geyer &amp; Swerdlow, 2001</xref>). <xref ref-type="bibr" rid="ref-10">Chung et al. (2011a)</xref> found, in mice, that MCH had no effect alone on PPI but that MCH did enhance the ability of lower doses of the DA1/DA2 dopamine receptor agonist apomorphine to suppress PPI. One implication of this finding is that simultaneous modulation of MCH and dopamine receptors might represent a novel therapy for treatment of schizophrenia, which would allow use of lower doses of dopamine modulators and thus reduce unwanted side effects. However, to fully understand the mechanism of such an interaction, it would be useful to know which brain region these dopamine and MCH agents might interact within, which could suggest additional methods through which neurons targeted by dopamine and MCH could be modulated. Dopamine and MCH receptors are present in many brain regions (<xref ref-type="bibr" rid="ref-31">Missale et al., 1998</xref>; <xref ref-type="bibr" rid="ref-41">Saito et al., 2001</xref>), and thus the region within which apomorphine and MCH might interact to suppress PPI remains unclear.</p>
      <p>We previously used <italic>in vitro</italic> electrophysiology and biochemistry to show that MCH can interact cooperatively with dopamine receptor agonists to increase activity of nucleus accumbens (NAcb) shell (NAshell) medium spiny neurons (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>). The NAshell is an important regulator of feeding, response to novelty, and some addiction- and reward-related behaviors including suppression of several forms of reward-related responding (<xref ref-type="bibr" rid="ref-12">Di Chiara, 2002</xref>; <xref ref-type="bibr" rid="ref-16">Georgescu et al., 2005</xref>; <xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-4">Besson et al., 2010</xref>; <xref ref-type="bibr" rid="ref-32">Morganstern et al., 2010</xref>; <xref ref-type="bibr" rid="ref-17">Ghazizadeh et al., 2012</xref>; <xref ref-type="bibr" rid="ref-29">LaLumiere, Smith &amp; Kalivas, 2012</xref>). In addition, the NAshell has been noted as a brain region which regulates PPI (<xref ref-type="bibr" rid="ref-27">Kodsi &amp; Swerdlow, 1997</xref>; <xref ref-type="bibr" rid="ref-1">Alsene, Fallace &amp; Bakshi, 2010</xref>), including where dopaminergic drugs can disrupt PPI (<xref ref-type="bibr" rid="ref-11">Devoto et al., 2012</xref>; <xref ref-type="bibr" rid="ref-30">Meyer &amp; Louilot, 2011</xref>; but see <xref ref-type="bibr" rid="ref-49">Swerdlow et al., 2007</xref>), as well as other behavioral models considered to reflect symptoms of schizophrenia such as behavioral inflexibility (<xref ref-type="bibr" rid="ref-15">Floresco, Zhang &amp; Enomoto, 2009</xref>) and disturbances of latent inhibition (<xref ref-type="bibr" rid="ref-34">Murphy et al., 2000</xref>; <xref ref-type="bibr" rid="ref-53">Weiner, 2003</xref>).</p>
      <p>Here, we have investigated whether MCH interacts with apomorphine to increase in action potential (AP) firing in the NAshell <italic>in vitro</italic>, and examined which dopamine receptors might be required for this increase in activity. A cooperative interaction between MCH and apomorphine <italic>in vitro</italic> could suggest that the NAshell is a brain region where MCH and apomorphine interact to suppress PPI.</p>
    </sec>
    <sec sec-type="methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Brain slice preparation and electrophysiology methods</title>
        <p>Male Sprague-Dawley rats (p21-35) were deeply anesthetized with pentobarbital (100 mg/kg, i.p.) in accordance with Institutional Animal Care and Use and National Institutes of Health Guidelines and under the guidance and approval of the IACUC Committee of the Ernest Gallo Clinic and Research Center. Transcardial perfusion was performed with ∼ 15 ml of ice-cold sucrose-aCSF (in mM: 75 sucrose, 87 NaCl, 2.5 KCl, 1.25 <named-content content-type="chemical-compound">NaH<sub>2</sub>PO<sub>4</sub></named-content>, 7 <named-content content-type="chemical-compound">MgCl<sub>2</sub></named-content>, 0.5 <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 25 <named-content content-type="chemical-compound">NaHCO<sub>3</sub></named-content>, 1 ascorbic acid) saturated with 95% <named-content content-type="chemical-compound">O<sub>2</sub></named-content> and 5% <named-content content-type="chemical-compound">CO<sub>2</sub></named-content>. The brain was rapidly removed and coronal slices (300 µm) were cut in this same sucrose-aCSF. Slices were transferred to the recovery chamber containing aCSF (in mM: 126 NaCl, 2.5 KCl, 1.2 <named-content content-type="chemical-compound">NaH<sub>2</sub>PO<sub>4</sub></named-content>, 1.2 <named-content content-type="chemical-compound">MgCl<sub>2</sub></named-content>, 2.4 <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 18 <named-content content-type="chemical-compound">NaHCO<sub>3</sub></named-content>, 11 glucose, with pH 7.2–7.4 and mOsm 304-306) at 31 °C and saturated with 95% <named-content content-type="chemical-compound">O<sub>2</sub></named-content> and 5% <named-content content-type="chemical-compound">CO<sub>2</sub></named-content>. 1 mM ascorbic acid was added to the aCSF in the recovery chamber just before adding the slices. Slices were incubated for 30 min-5 h prior to recordings.</p>
        <p>Whole-cell current-clamp recordings were made from NAshell medium spiny neurons, identified as previously described (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>). Patch-clamping was performed as described (<xref ref-type="bibr" rid="ref-21">Hopf et al., 2010a</xref>; <xref ref-type="bibr" rid="ref-24">Hopf et al., 2010b</xref>) using 3–5 MΩ glass electrodes filled with a potassium methanesulfonate-based internal solution (130 mM KOH, 105 mM methanesulfonic acid, 17 mM hydrochloric acid, 20 mM HEPES, 0.2 mM EGTA, 2.8 mM NaCl, 2.5 mg/ml MgATP, 0.25 mg/ml NaGTP, pH 7.2–7.4, 275–285 mOsm). Patch-clamp data were collected at 15 kHz and filtered at 2 kHz using Clampex 9.2 or 10 and a Multiclamp 700A patch amplifier (Axon Instruments, Union City, CA). During electrophysiology experiments, slices were submerged and continuously perfused (using a peristaltic pump, ∼2.5 ml/min) with carbogen-bubbled aCSF warmed to 31–32 °C, and supplemented with DNQX (10 µM, to block AMPA receptors) and picrotoxin (50 µM, to block GABA-A receptors). Here, we decided to use a concentration of 2 µM α-flupenthixol, a D1/D2 receptor antagonist. Previous reports have reported divergent concentrations of α-flupenthixol in slice experiments (10 µM in <xref ref-type="bibr" rid="ref-6">Cameron &amp; Williams, 1993</xref>, 0.1 µM in <xref ref-type="bibr" rid="ref-2">Benardo &amp; Prince, 1982</xref>). Also, behavioral experiments injecting α-flupenthixol into the NAcb tend to use higher concentrations (≥5 µg, <xref ref-type="bibr" rid="ref-14">Di Ciano et al., 2001</xref>; <xref ref-type="bibr" rid="ref-42">Saunders &amp; Robinson, 2012</xref>) relative to that used for SCH23390 or raclopride (1–2 µg, see <xref ref-type="bibr" rid="ref-55">Yun et al., 2004</xref>). Thus, we chose 2 µM, which is somewhat higher than the 1 µM we use for SCH23390 and raclopride <italic>in vitro</italic>. In addition, α-flupenthixol had no effect of firing on its own (<xref ref-type="fig" rid="fig-2">Fig. 2C</xref>, −0.3 ± 2.3% change in firing versus basal, <italic>P</italic> = 0.116 paired <italic>t</italic>-test), in agreement with our previous studies that blockers more selective for D1 or D2 receptors have no effect on firing on their own in the NAshell (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>).</p>
        <fig id="fig-1">
          <object-id pub-id-type="doi">10.7717/peerj.61/fig-1</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Increased NAshell firing with apomorphine and MCH.</title>
            <p>(A, B) (A) Example traces and (B) grouped data across time showing that 1 µM MCH (MCH) and 3 µM apomorphine (Apo3) interact to enhance firing in NAshell neurons <italic>in vitro</italic>, while 3 µM apomorphine had no effect alone. (C) 10 µM apomorphine (Apo10) was sufficient to enhance NAshell firing. (D) 1 µM MCH in combination with 1 µM apomorphine did not increase firing. (E) 1 µM MCH in combination with 10 µM apomorphine significantly increased firing. (F) 3 µM apomorphine in combination with 1 µM MCH significantly enhanced firing under conditions where AMPA and GABA<sub>A</sub> receptors were not blocked. (G) 3 µM apomorphine + 1 µM MCH did not increase firing when the PKA inhibitor peptide PKI (20 µM) was included in the intracellular pipette.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/61/fig-1.png"/>
        </fig>
        <fig id="fig-2">
          <object-id pub-id-type="doi">10.7717/peerj.61/fig-2</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Dopamine receptor inhibitors prevent the apomorphine/MCH enhancement of firing.</title>
            <p>Enhancement of NAshell firing by MCH (1 µM) + apomorphine (3 µM) was prevented by pre-exposure to (A) the DA1 receptor blocker SCH23390 (SCH, 1 µM), (B) the DA2 receptor blocker raclopride (Racl, 1 µM), (C) the D1/D2 blocker α-flupenthixol (flupen, 2 µM), or (D) the MCH receptor blocker TPI (2 µM).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/61/fig-2.png"/>
        </fig>
      </sec>
      <sec>
        <title>AP generation, analyses and statistics</title>
        <p>The resting membrane potential was determined just after breaking into a neuron, and each neuron was then brought to a resting potential of ∼−85 mV by passage of DC current via the patch amplifier before further firing experiments. To generate APs, neurons in current clamp were depolarized with a series of 7 or 8 500-ms current pulses, with 20 pA between each current pulse, and where the initial current pulse for each neuron was just sub-threshold for firing. This series of current pulses was applied every 30 s throughout the experiment, and was alternated with hyperpolarizing steps (−50 and −100 pA) to examine input resistance.</p>
        <p>To analyze changes in firing for each cell, a depolarizing step was chosen that gave ∼6–7 APs in the basal condition. We then determined the number of APs at this current step at all time points during the experiment for that cell. The baseline firing rate was determined from the average of firing in the 4 min before addition of apomorphine ± MCH, and was normalized to 100% for each cell. The percent change in firing versus baseline was then determined by taking the average of firing during the 6th–8th min of apomorphine ± MCH exposure. Statistics across groups were determined using these averaged values for the peak change in firing. Thus, a one-way ANOVA was calculated comparing 3 µM apomorphine + MCH with and without dopamine or MCH receptor blockers, and also comparing with 3 µM apomorphine alone; Tukey was used as a post-hoc. <italic>P</italic> &lt; 0.05 was taken to indicate significant differences. Data are shown as mean + /− SEM.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>To examine whether apomorphine and MCH interacted <italic>in vitro</italic> to alter AP firing in NAshell neurons, we performed <italic>in vitro</italic> whole-cell patch-clamp electrophysiology experiments in brain slices containing NAshell medium spiny neurons. A series of 500 ms depolarizing steps of varying current intensity were applied every 30 s (see Methods) to generate AP firing. As shown in <xref ref-type="fig" rid="fig-1">Figs. 1A</xref> and <xref ref-type="fig" rid="fig-1">1B</xref>, 3 µM apomorphine did not enhance NAshell firing on its own (<italic>n</italic> = 7, 0.2 ± 3.8% change in firing versus basal), although 10 µM apomorphine was sufficient to enhance firing (<xref ref-type="fig" rid="fig-1">Fig. 1C</xref>, <italic>n</italic> = 7, 24.2 ± 8.4% change in firing versus basal, paired <italic>t</italic>-test <italic>P</italic> = 0.021 baseline versus 10 µM apomorphine). In contrast, 3 µM apomorphine significantly enhanced firing when combined with 1 µM MCH (<xref ref-type="fig" rid="fig-1">Figs. 1A</xref> and <xref ref-type="fig" rid="fig-1">1B</xref>, <italic>n</italic> = 7, 24.4 ± 7.8% change in firing versus basal, <italic>P</italic> &lt; 0.01 versus 3 µM apomorphine alone). We also found that 1 µM MCH in combination with 10 µM apomorphine significantly increased firing (<xref ref-type="fig" rid="fig-1">Fig. 1E</xref>, <italic>n</italic> = 5, 29.5 ±6.3% change in firing versus basal, <italic>P</italic> = 0.010 paired <italic>t</italic>-test). 1 µM MCH in combination with 1 µM apomorphine did not change firing (<xref ref-type="fig" rid="fig-1">Fig. 1D</xref>, <italic>n</italic> = 6, 0.7 ± 2.8% change in firing versus basal, <italic>P</italic> = 0.798 paired <italic>t</italic>-test), suggesting that a minimal amount of dopamine receptor activation was required to interact with MCH to increase NAshell firing. Previous studies (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>) have shown that MCH either does not increase firing (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>) or reduces firing (<xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>) in the NAshell when applied alone; in either case it does not enhance NAshell firing when applied alone. Thus, our results suggest that MCH can interact with a sub-threshold dose of apomorphine (3 µM) to increase NAshell firing <italic>in vitro</italic>.</p>
      <p>Since our experiments were performed in the presence of DNQX to inhibit spontaneous AMPA receptor activation and picrotoxin to inhibit spontaneous GABA<sub>A</sub> receptor activation (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-23">Hopf et al., 2005</xref>), we next examined whether 3 µM apomorphine in combination with 1 µM MCH increased firing in the absence of these blockers, which might reflect more physiological conditions. As shown in <xref ref-type="fig" rid="fig-1">Fig. 1F</xref>, apomorphine + MCH did significantly enhance firing under conditions where AMPA and GABA<sub>A</sub> receptors were not blocked (<italic>n</italic> = 5, 30.3 ± 9.6% change in firing versus basal, <italic>P</italic> = 0.030 paired <italic>t</italic>-test), suggesting that the ability of apomorphine + MCH to enhance firing persisted even when AMPA and GABA<sub>A</sub> receptors could be modulated by possible dopaminergic effects on spontaneous release (<xref ref-type="bibr" rid="ref-36">Nicola &amp; Malenka, 1997</xref>; but see <xref ref-type="bibr" rid="ref-38">Ortinski et al., 2012</xref>) or spontaneous activity of GABA interneurons (<xref ref-type="bibr" rid="ref-7">Centonze et al., 2003</xref>).</p>
      <p>A number of studies suggest that PKA is an central regulator of NAcb dopaminergic signaling (<xref ref-type="bibr" rid="ref-48">Svenningsson et al., 2004</xref>) including dopamine receptor enhancement of NAshell firing (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>). In agreement, the increase in firing with 3 µM apomorphine + MCH was prevented by including the PKA inhibitor peptide PKI (20 µM, <xref ref-type="bibr" rid="ref-23">Hopf et al., 2005</xref>) in the intracellular pipette solution (<xref ref-type="fig" rid="fig-1">Fig. 1G</xref>; <italic>n</italic> = 5, 2.1 ± 5.1% change in firing versus basal, <italic>P</italic> = 0.030 vs no PKI in <xref ref-type="fig" rid="fig-1">Fig. 1B</xref>).</p>
      <p>We next determined whether the apomorphine + MCH increase in firing required dopamine type 1 (DA1) and/or dopamine type 2 (DA2) receptors. Application of 3 µM apomorphine + MCH did not increase firing after 10 min pre-exposure to a blocker for DA1 receptors (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>, SCH23390 1 µM, <italic>n</italic> = 5, −3.9 ± −2.2% change in firing versus basal), a blocker for DA2 receptors (<xref ref-type="fig" rid="fig-2">Fig. 2B</xref>, raclopride 1 µM, <italic>n</italic> = 6, −0.1 ± 8.2% change in firing versus basal) or a blocker that targets both DA1 and DA2 receptors (<xref ref-type="fig" rid="fig-2">Fig. 2C</xref>, α-flupenthixol 2 µM, <italic>n</italic> = 4, −4.2 ± 3.4% change in firing versus basal). The increase in NAshell with 3 µM apomorphine + MCH was also prevented by pre-exposure to the MCH receptor inhibitor TPI (2 µM, <xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>) (<xref ref-type="fig" rid="fig-2">Fig. 2D</xref>, <italic>n</italic> = 6, 3.0 ± 2.4% change in firing versus basal), confirming the importance of MCH receptors in the action of apomorphine + MCH. A one-way ANOVA comparing the groups shown in <xref ref-type="fig" rid="fig-3">Fig. 3</xref> found a significant effect across groups (<italic>F</italic>(5, 29) = 4.140, <italic>P</italic> = 0.006), and post-hoc analyses showed that the 3 µM apomorphine + MCH enhancement in firing was significantly prevented by pre-exposure to any of the four receptor blockers tested here (<italic>P</italic> &lt; 0.05). Together, these results suggest that MCH in combination with 3 µM apomorphine was able to enhance firing in NAshell neurons, and that this increase in firing required activity at both DA1 and DA2 receptors as well as MCH receptors and PKA.</p>
      <fig id="fig-3">
        <object-id pub-id-type="doi">10.7717/peerj.61/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>ANOVA for dopamine receptor mediation of apomorphine/MCH enhancement of firing.</title>
          <p>Significant effect (*<italic>P</italic> &lt; 0.05) of MCH +apomorphine (3 µM) versus 3 µM apomorphine alone or versus MCH + 3 µM apomorphine after pre-exposure to antagonists for DA1 (SCH), DA2 (Racl), DA1/DA2 (flupen) or MCH (TPI) receptors.</p>
        </caption>
        <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/61/fig-3.png"/>
      </fig>
      <p>To further explore the mechanism underlying the apomorphine/MCH increase in firing, we analyzed the input resistance and several aspects of the action potential waveform from all agonist conditions that enhanced action potential firing (<xref ref-type="table" rid="table-1">Table 1</xref>). In agreement with our previous work (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>), increases in firing with apomorphine/MCH were not accompanied by any changes in these parameters, suggesting that the apomorphine/MCH increase in firing did not reflect alterations in inward rectifying channels or sodium or fast potassium channels active during an action potential (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-24">Hopf et al., 2010b</xref>).</p>
      <table-wrap id="table-1">
        <object-id pub-id-type="doi">10.7717/peerj.61/table-1</object-id>
        <label>Table 1</label>
        <caption>
          <title>Enhancement of firing with apomorphine + /− MCH was not accompanied by changes in input resistance (Rinput) or several action potential waveform parameters.</title>
          <p>(<italic>P</italic> value for paired <italic>t</italic>-test comparisons between values at baseline and values after addition of apomorphine + /− MCH). Analyses were only performed under conditions where firing was enhanced. “Apo3 + MCH without blockers” indicates experiments where Apo3 + MCH was added in the absence of picrotoxin and DNQX. “AP” indicates action potential, and waveform parameters were determined as previously described (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-24">Hopf et al., 2010b</xref>). Although there is some variability among groups in terms of basal input resistance, a one-way ANOVA found no differences in basal input resistance across the four groups tested (<italic>F</italic>(3, 20) = 1.102, <italic>P</italic> = 0.372).</p>
        </caption>
        <alternatives>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/61/table-1.png"/>
          <table>
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Measure</th>
                <th align="left">Basal</th>
                <th align="left">Apo3 + MCH</th>
                <th align="left">Basal</th>
                <th align="left">Apo10</th>
                <th align="left">Basal</th>
                <th align="left">Apo10 + MCH</th>
                <th align="left">Basal</th>
                <th align="left">Apo3 + MCH <break/>without blockers</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Rinput (MΩ)</td>
                <td align="left">174.6 ± 21.4</td>
                <td align="left">184.6 ± 21.0 <break/><italic>P</italic> = 0.083</td>
                <td align="left">158.7 ± 28.0</td>
                <td align="left">164.1 ± 31.3 <break/><italic>P</italic> = 0.345</td>
                <td align="left">127.8 ± 16.8</td>
                <td align="left">143.8 ± 18.4 <break/><italic>P</italic> = 0.149</td>
                <td align="left">126.8 ± 14.8</td>
                <td align="left">129.9 ± 14.7 <break/><italic>P</italic> = 0.554</td>
              </tr>
              <tr>
                <td align="left">AP amplitude (mV)</td>
                <td align="left">80.9 ± 2.5</td>
                <td align="left">78.8 ± 3.6 <break/><italic>P</italic> = 0.168</td>
                <td align="left">79.1 ± 1.6</td>
                <td align="left">78.7 ± 1.5 <break/><italic>P</italic> = 0.583</td>
                <td align="left">82.4 ± 3.1</td>
                <td align="left">80.8 ± 4.7 <break/><italic>P</italic> = 0.430</td>
                <td align="left">78.8 ± 2.5</td>
                <td align="left">77.4 ± 3.6 <break/><italic>P</italic> = 0.083</td>
              </tr>
              <tr>
                <td align="left">AP threshold (mV)</td>
                <td align="left">−45.5 ± 1.7</td>
                <td align="left">−46.2 ± 2.3 <break/><italic>P</italic> = 0.343</td>
                <td align="left">−47.3 ± 2.3</td>
                <td align="left">−48.1 ± 2.5 <break/><italic>P</italic> = 0.097</td>
                <td align="left">−46.2 ± 1.2</td>
                <td align="left">−47.7 ± 1.1 <break/><italic>P</italic> = 0.077</td>
                <td align="left">−44.6 ± 2.6</td>
                <td align="left">−45.5 ± 2.4 <break/><italic>P</italic> = 0.182</td>
              </tr>
              <tr>
                <td align="left">AP half-width (ms)</td>
                <td align="left">1.85 ± 0.16</td>
                <td align="left">1.79 ± 0.09 <break/><italic>P</italic> = 0.523</td>
                <td align="left">1.77 ± 0.09</td>
                <td align="left">1.83 ± 0.08 <break/><italic>P</italic> = 0.319</td>
                <td align="left">1.77 ± 0.06</td>
                <td align="left">1.82 ± 0.09 <break/><italic>P</italic> = 0.278</td>
                <td align="left">1.83 ± 0.11</td>
                <td align="left">1.82 ± 0.13 <break/><italic>P</italic> = 0.983</td>
              </tr>
              <tr>
                <td align="left">Peak of the fast AHP (mV)</td>
                <td align="left">−59.5 ± 2.3</td>
                <td align="left">−59.8 ± 3.0 <break/><italic>P</italic> = 0.700</td>
                <td align="left">−63.1 ± 1.5</td>
                <td align="left">−63.3 ± 1.6 <break/><italic>P</italic> = 0.603</td>
                <td align="left">−60.3 ± 1.8</td>
                <td align="left">−61.4 ± 1.9 <break/><italic>P</italic> = 0.240</td>
                <td align="left">−58.3 ± 3.1</td>
                <td align="left">−58.5 ± 3.0 <break/><italic>P</italic> = 0.449</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Using <italic>in vitro</italic> whole-cell patch-clamp electrophysiology, we found that MCH and apomorphine in combination enhanced firing of NAshell neurons; an increase in firing was not observed with this concentration of apomorphine on its own, and MCH alone was previously shown not to increase NAshell firing (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>). We also found that the increase in NAshell firing with apomorphine + MCH was inhibited by antagonists of either DA1, DA2, or MCH receptors or by an agent that blocks both DA1 and DA2 receptors. These results concur with our previous findings that DA1 and DA2 receptors interact to enhance NAshell activity (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-23">Hopf et al., 2005</xref>; <xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>) (see also <xref ref-type="bibr" rid="ref-45">Seif et al., 2011</xref> in the NAcb core and <xref ref-type="bibr" rid="ref-26">Inoue et al., 2007</xref>), and suggest that apomorphine enhancement of firing required both DA1 and DA2 receptors in addition to an interaction with MCH receptors. The apomorphine + MCH increase in firing was prevented by a PKA inhibitor, consistent with previous work showing that PKA is an important mediator of NAcb dopaminergic signaling involving DA1 receptors (<xref ref-type="bibr" rid="ref-48">Svenningsson et al., 2004</xref>), including dopamine receptor enhancement of NAshell firing (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>). Our results also suggest that the NAshell may represent the brain region where lower doses of apomorphine can interact with MCH <italic>in vivo</italic> to suppress PPI (<xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>).</p>
      <p>We previously showed that MCH in combination with both DA1 and DA2 receptor agonists significantly enhanced NAshell firing <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>), but we did not determine whether DA1 or DA2 might itself be sufficient to interact with MCH to enhance firing. Thus, the present results with DA receptor antagonists provide new information that apomorphine activation of both DA1 and DA2 receptors was required for apomorphine to interact with MCH to enhance firing. This agrees with our previous work that dopamine enhancement of firing can be prevented by either DA1 or DA2 receptor antagonists (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>). We should note that the DA1 receptor blocker SCH23390 has been shown to directly inhibit GIRK channels (<xref ref-type="bibr" rid="ref-28">Kuzhikandathil &amp; Oxford, 2002</xref>). However, when acting through this mechanism, SCH23390 directly depolarizes cells and enhances action potential firing; we observed no effect of SCH23390 alone on firing in a previous study (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>) or here with a shorter baseline period before adding SCH23390, suggesting that SCH23390 did not directly alter GIRK function under the conditions studied here.</p>
      <p>Our results suggesting a DA1/DA2 interaction to increase firing also agree with a larger behavioral literature that has shown that a number of behaviors are mediated through a DA1/DA2 interaction in the NAcb (e.g. <xref ref-type="bibr" rid="ref-37">Nowend et al., 2001</xref>; <xref ref-type="bibr" rid="ref-3">Bernal et al., 2008</xref>; <xref ref-type="bibr" rid="ref-46">Shin et al., 2008</xref>; <xref ref-type="bibr" rid="ref-20">Hasbi, O’Dowd &amp; George, 2011</xref>), and for cocaine-primed reinstatement (<xref ref-type="bibr" rid="ref-43">Schmidt &amp; Pierce, 2006</xref>) and intra-NAshell self-administration of dopamine receptor activators (<xref ref-type="bibr" rid="ref-25">Ikemoto et al., 1997</xref>), DA1 and DA2 receptors interact cooperatively to support behavior. In contrast, some behaviors are regulated differentially by DA1 and DA2 receptors in the NAcb (<xref ref-type="bibr" rid="ref-18">Goto &amp; Grace, 2005</xref>; <xref ref-type="bibr" rid="ref-39">Pezze, Dalley &amp; Robbins, 2007</xref>; <xref ref-type="bibr" rid="ref-19">Haluk &amp; Floresco, 2009</xref>); at a cellular level, DA1 and DA2 receptors can have divergent effects, e.g., on glutamate receptor function (<xref ref-type="bibr" rid="ref-16">Georgescu et al., 2005</xref>; <xref ref-type="bibr" rid="ref-18">Goto &amp; Grace, 2005</xref>; <xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>; <xref ref-type="bibr" rid="ref-52">Wang et al., 2012</xref>). Here, we found that apomorphine + MCH increased firing when AMPA and GABA<sub>A</sub> receptors were not blocked pharmacologically, suggesting that the increase in firing still occurred in the presence of any possible dopaminergic effects on glutamate or GABA<sub>A</sub> receptors due to spontaneous release (<xref ref-type="bibr" rid="ref-36">Nicola &amp; Malenka, 1997</xref>; but see <xref ref-type="bibr" rid="ref-38">Ortinski et al., 2012</xref>) or spontaneous activity of GABAergic interneurons (<xref ref-type="bibr" rid="ref-7">Centonze et al., 2003</xref>). Although the mechanism through which DA1 and DA2 receptors in the NAcb might interact positively under some conditions remain unclear, studies have described a mechanism requiring DA1-DA2 heterodimers (<xref ref-type="bibr" rid="ref-20">Hasbi, O’Dowd &amp; George, 2011</xref>) or G protein beta-gamma subunits (<xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-26">Inoue et al., 2007</xref>) and PKA (here; <xref ref-type="bibr" rid="ref-22">Hopf et al., 2003</xref>; <xref ref-type="bibr" rid="ref-26">Inoue et al., 2007</xref>).</p>
      <p>We should also note that studies of MCH alone on NAshell activity have yielded somewhat mixed results. We found that MCH alone did alter neuronal firing or the levels of phospho-DARPP but that MCH in combination with dopamine receptor agonists enhanced both measures (<xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>). In contrast, Sears and colleagues (<xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>) found that MCH alone can inhibit firing and phospho-GluR1 in the NAshell. Although the reason for these mixed results is not completely apparent, it is possible that MCH would be able to modulate firing when combined with activation of dopamine receptors but have different effects on firing when applied alone. Such divergent effects of receptor agonists alone versus in combination with other types of receptor agonists has previously been shown, for example as shown with adenosine/cannabinoid receptor interactions (<xref ref-type="bibr" rid="ref-50">Tebano, Martire &amp; Popoli, 2012</xref>).</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>We found that MCH interacted with subthreshold levels of the dopamine receptor agonist apomorphine to enhance firing of NAshell neurons <italic>in vitro</italic>. Apomorphine + MCH enhancement of NAshell firing required both DA1 and DA2 receptors as well as MCH receptors. Our <italic>in vitro</italic> results parallel what is observed <italic>in vivo</italic> where MCH enhances the ability of lower doses of apomorphine to suppress PPI, an animal model for some aspects of schizophrenia in humans. Thus, the NAshell may represent the brain region where MCH and apomorphine interact to regulate the expression of PPI and thus could regulate some symptoms of human schizophrenia. Apomorphine within the NAshell can also reduce withdrawal-related anxiety (<xref ref-type="bibr" rid="ref-40">Radke &amp; Gewirtz, 2012</xref>), suggesting that this mechanism might be relevant to other psychiatric diseases such as depression which are modulated through MCH (<xref ref-type="bibr" rid="ref-16">Georgescu et al., 2005</xref>; <xref ref-type="bibr" rid="ref-35">Nestler &amp; Carlezon, 2006</xref>; <xref ref-type="bibr" rid="ref-47">Shirayama &amp; Chaki, 2006</xref>; <xref ref-type="bibr" rid="ref-8">Chung et al., 2009</xref>; <xref ref-type="bibr" rid="ref-32">Morganstern et al., 2010</xref>; <xref ref-type="bibr" rid="ref-44">Sears et al., 2010</xref>; <xref ref-type="bibr" rid="ref-33">Mul et al., 2011</xref>; <xref ref-type="bibr" rid="ref-10">Chung et al., 2011a</xref>; <xref ref-type="bibr" rid="ref-9">Chung et al., 2011b</xref>).</p>
    </sec>
  </body>
  <back>
    <sec sec-type="additional-information">
      <title>Additional Information and Declarations</title>
      <fn-group content-type="competing-interests">
        <title>Competing Interests</title>
        <fn id="conflict-1" fn-type="con">
          <p>Olivier Civelli is an Academic Editor for PeerJ. The authors declare no other competing interests.</p>
        </fn>
      </fn-group>
      <fn-group content-type="author-contributions">
        <title>Author Contributions</title>
        <fn id="contribution-1" fn-type="con">
          <p><xref ref-type="contrib" rid="author-1">F Woodward Hopf</xref> and <xref ref-type="contrib" rid="author-2">Taban Seif</xref> conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper.</p>
        </fn>
        <fn id="contribution-2" fn-type="con">
          <p><xref ref-type="contrib" rid="author-3">Shinjae Chung</xref> conceived and designed the experiments.</p>
        </fn>
        <fn id="contribution-3" fn-type="con">
          <p><xref ref-type="contrib" rid="author-4">Olivier Civelli</xref> conceived and designed the experiments, wrote the paper.</p>
        </fn>
      </fn-group>
      <fn-group content-type="other">
        <title>Animal Ethics</title>
        <fn id="addinfo-1" fn-type="other">
          <p>The following information was supplied relating to ethical approvals (i.e. approving body and any reference numbers):</p>
          <p>“The animal use in this study was performed in accordance with Institutional Animal Care and Use and National Institutes of Health Guidelines and under the guidance and approval of the IACUC Committee of the Ernest Gallo Clinic and Research Center.” The IACUC approval number is 11.09.244.</p>
        </fn>
      </fn-group>
    </sec>
    <ref-list content-type="authoryear">
      <title>References</title>
      <ref id="ref-1">
        <label>Alsene, Fallace &amp; Bakshi (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alsene</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Fallace</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bakshi</surname>
              <given-names>VP</given-names>
            </name>
          </person-group>
          <article-title>Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2010">2010</year>
          <volume>35</volume>
          <fpage>2346</fpage>
          <lpage>2356</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2010.106</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-2">
        <label>Benardo &amp; Prince (1982)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benardo</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Dopamine action on hippocampal pyramidal cells</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="1982">1982</year>
          <volume>2</volume>
          <fpage>415</fpage>
          <lpage>423</lpage>
        </element-citation>
      </ref>
      <ref id="ref-3">
        <label>Bernal et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernal</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Dostova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kest</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abayev</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kandova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Touzani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sclafani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bodnar</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Role of dopamine D1 and D2 receptors in the nucleus accumbens shell on the acquisition and expression of fructose-conditioned flavor-flavor preferences in rats</article-title>
          <source>Behavioural Brain Research</source>
          <year iso-8601-date="2008">2008</year>
          <volume>190</volume>
          <fpage>59</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbr.2008.02.003</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-4">
        <label>Besson et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Besson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Belin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Theobald</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Castel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beckett</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Crittenden</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Everitt</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Dalley</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2010">2010</year>
          <volume>35</volume>
          <fpage>560</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2009.162</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-5">
        <label>Braff, Geyer &amp; Swerdlow (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braff</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Geyer</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies</article-title>
          <source>Psychopharmacology</source>
          <year iso-8601-date="2001">2001</year>
          <volume>156</volume>
          <fpage>234</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1007/s002130100810</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-6">
        <label>Cameron &amp; Williams (1993)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cameron</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Dopamine D1 receptors facilitate transmitter release</article-title>
          <source>Nature</source>
          <year iso-8601-date="1993">1993</year>
          <volume>366</volume>
          <fpage>344</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="doi">10.1038/366344a0</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-7">
        <label>Centonze et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Centonze</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grande</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Usiello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gubellini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Erbs</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Pisani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tognazzi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bernardi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moratalla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Borrelli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Calabresi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2003">2003</year>
          <volume>23</volume>
          <fpage>6245</fpage>
          <lpage>6254</lpage>
        </element-citation>
      </ref>
      <ref id="ref-8">
        <label>Chung et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Nagasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Belluzzi</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Civelli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The melanin-concentrating hormone system modulates cocaine reward</article-title>
          <source>Proceedings of the National Academy of Sciences USA</source>
          <year iso-8601-date="2009">2009</year>
          <volume>106</volume>
          <fpage>6772</fpage>
          <lpage>6777</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0811331106</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-9">
        <label>Chung et al. (2011b)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Civelli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists</article-title>
          <source>Journal of Molecular Neuroscience</source>
          <year iso-8601-date="2011">2011b</year>
          <volume>43</volume>
          <fpage>115</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1007/s12031-010-9411-4</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-10">
        <label>Chung et al. (2011a)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Verheij</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Hesseling</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>van Vugt</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Buell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Belluzzi</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Geyer</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Martens</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Civelli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders</article-title>
          <source>PLoS ONE</source>
          <year iso-8601-date="2011">2011a</year>
          <volume>6</volume>
          <elocation-id>e19286</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0019286</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-11">
        <label>Devoto et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devoto</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Frau</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bini</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pillolla</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Saba</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Flore</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Corona</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marrosu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bortolato</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation</article-title>
          <source>Psychoneuroendocrinology</source>
          <year iso-8601-date="2012">2012</year>
          <volume>37</volume>
          <fpage>1630</fpage>
          <lpage>1645</lpage>
          <pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.09.018</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-12">
        <label>Di Chiara (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Chiara</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Nucleus accumbens shell and core dopamine: differential role in behavior and addiction</article-title>
          <source>Behavioural Brain Research</source>
          <year iso-8601-date="2002">2002</year>
          <volume>137</volume>
          <fpage>75</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1016/S0166-4328(02)00286-3</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-13">
        <label>Di Ciano (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Ciano</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Distinct contributions of dopamine receptors in the nucleus accumbens core or shell to established cocaine reinforcement under a second-order schedule</article-title>
          <source>European Neuropsychopharmacology</source>
          <year iso-8601-date="2008">2008</year>
          <volume>18</volume>
          <fpage>888</fpage>
          <lpage>896</lpage>
          <pub-id pub-id-type="doi">10.1016/j.euroneuro.2008.07.007</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-14">
        <label>Di Ciano et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Ciano</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cardinal</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Cowell</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Everitt</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2001">2001</year>
          <volume>21</volume>
          <fpage>9471</fpage>
          <lpage>9477</lpage>
        </element-citation>
      </ref>
      <ref id="ref-15">
        <label>Floresco, Zhang &amp; Enomoto (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Floresco</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Enomoto</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Neural circuits subserving behavioral flexibility and their relevance to schizophrenia</article-title>
          <source>Behavioural Brain Research</source>
          <year iso-8601-date="2009">2009</year>
          <volume>204</volume>
          <fpage>396</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.001</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-16">
        <label>Georgescu et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georgescu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sears</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Hommel</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Barrot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bolanos</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Marsh</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bednarek</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bibb</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Maratos-Flier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nestler</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>DiLeone</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2005">2005</year>
          <volume>25</volume>
          <fpage>2933</fpage>
          <lpage>2940</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1714-04.2005</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-17">
        <label>Ghazizadeh et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghazizadeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ambroggi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Odean</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fields</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Prefrontal cortex mediates extinction of responding by two distinct neural mechanisms in accumbens shell</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2012">2012</year>
          <volume>32</volume>
          <fpage>726</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3891-11.2012</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-18">
        <label>Goto &amp; Grace (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior</article-title>
          <source>Nature Neuroscience</source>
          <year iso-8601-date="2005">2005</year>
          <volume>8</volume>
          <fpage>805</fpage>
          <lpage>812</lpage>
          <pub-id pub-id-type="doi">10.1038/nn1471</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-19">
        <label>Haluk &amp; Floresco (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haluk</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Floresco</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Ventral striatal dopamine modulation of different forms of behavioral flexibility</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>34</volume>
          <fpage>2041</fpage>
          <lpage>2052</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2009.21</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-20">
        <label>Hasbi, O’Dowd &amp; George (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hasbi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>O’Dowd</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance</article-title>
          <source>Molecular Brain</source>
          <year iso-8601-date="2011">2011</year>
          <volume>4</volume>
          <fpage>26</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1186/1756-6606-4-26</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-21">
        <label>Hopf et al. (2010a)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Bowers</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seif</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Tye</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence</article-title>
          <source>Neuron</source>
          <year iso-8601-date="2010">2010a</year>
          <volume>65</volume>
          <fpage>682</fpage>
          <lpage>694</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.015</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-22">
        <label>Hopf et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Cascini</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2003">2003</year>
          <volume>23</volume>
          <fpage>5079</fpage>
          <lpage>5087</lpage>
        </element-citation>
      </ref>
      <ref id="ref-23">
        <label>Hopf et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Mailliard</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2005">2005</year>
          <volume>25</volume>
          <fpage>985</fpage>
          <lpage>989</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3099-04.2005</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-24">
        <label>Hopf et al. (2010b)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Seif</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mohamedi</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The small-conductance calcium-activated potassium channel is a key modulator of firing and long-term depression in the dorsal striatum</article-title>
          <source>European Journal of Neuroscience</source>
          <year iso-8601-date="2010">2010b</year>
          <volume>31</volume>
          <fpage>1946</fpage>
          <lpage>1959</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07231.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-25">
        <label>Ikemoto et al. (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ikemoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Glazier</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>McBride</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="1997">1997</year>
          <volume>17</volume>
          <fpage>8580</fpage>
          <lpage>8587</lpage>
        </element-citation>
      </ref>
      <ref id="ref-26">
        <label>Inoue et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D(1)/D(2) and adenosine A(2A) receptors</article-title>
          <source>Journal of Pharmacology and Experimental Therapeutics</source>
          <year iso-8601-date="2007">2007</year>
          <volume>322</volume>
          <fpage>23</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.107.120675</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-27">
        <label>Kodsi &amp; Swerdlow (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kodsi</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat</article-title>
          <source>Brain Research</source>
          <year iso-8601-date="1997">1997</year>
          <volume>773</volume>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-8993(97)00869-X</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-28">
        <label>Kuzhikandathil &amp; Oxford (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuzhikandathil</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Oxford</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels</article-title>
          <source>Molecular Pharmacology</source>
          <year iso-8601-date="2002">2002</year>
          <volume>62</volume>
          <fpage>119</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.62.1.119</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-29">
        <label>LaLumiere, Smith &amp; Kalivas (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LaLumiere</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Kalivas</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Neural circuit competition in cocaine-seeking: roles of the infralimbic cortex and nucleus accumbens shell</article-title>
          <source>European Journal of Neuroscience</source>
          <year iso-8601-date="2012">2012</year>
          <volume>35</volume>
          <fpage>614</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.07991.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-30">
        <label>Meyer &amp; Louilot (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Louilot</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Latent inhibition-related dopaminergic responses in the nucleus accumbens are disrupted following neonatal transient inactivation of the ventral subiculum</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2011">2011</year>
          <volume>36</volume>
          <fpage>1421</fpage>
          <lpage>1432</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2011.26</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-31">
        <label>Missale et al. (1998)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Missale</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Jaber</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Caron</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Dopamine receptors: from structure to function</article-title>
          <source>Physiological Reviews</source>
          <year iso-8601-date="1998">1998</year>
          <volume>78</volume>
          <fpage>189</fpage>
          <lpage>225</lpage>
        </element-citation>
      </ref>
      <ref id="ref-32">
        <label>Morganstern et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morganstern</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>GQ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Barson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Zhiyu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hoebel</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Leibowitz</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Role of melanin-concentrating hormone in the control of ethanol consumption: region-specific effects revealed by expression and injection studies</article-title>
          <source>Physiology and Behavior</source>
          <year iso-8601-date="2010">2010</year>
          <volume>101</volume>
          <fpage>428</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="doi">10.1016/j.physbeh.2010.07.009</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-33">
        <label>Mul et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mul</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>la Fleur</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Toonen</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Afrasiab-Middelman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Binnekade</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schetters</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Verheij</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Sears</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Homberg</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Schoffelmeer</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Adan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>DiLeone</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>De Vries</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Cuppen</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Chronic loss of melanin-concentrating hormone affects motivational aspects of feeding in the rat</article-title>
          <source>PLoS ONE</source>
          <year iso-8601-date="2011">2011</year>
          <volume>6</volume>
          <elocation-id>e19600</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0019600</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-34">
        <label>Murphy et al. (2000)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Pezze</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Feldon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heidbreder</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus</article-title>
          <source>Neuroscience</source>
          <year iso-8601-date="2000">2000</year>
          <volume>97</volume>
          <fpage>469</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00043-9</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-35">
        <label>Nestler &amp; Carlezon (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nestler</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Carlezon</surname>
              <given-names>WA</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>The mesolimbic dopamine reward circuit in depression</article-title>
          <source>Biological Psychiatry</source>
          <year iso-8601-date="2006">2006</year>
          <volume>59</volume>
          <fpage>1151</fpage>
          <lpage>1159</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.09.018</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-36">
        <label>Nicola &amp; Malenka (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicola</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Malenka</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="1997">1997</year>
          <volume>17</volume>
          <fpage>5697</fpage>
          <lpage>5710</lpage>
        </element-citation>
      </ref>
      <ref id="ref-37">
        <label>Nowend et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nowend</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Arizzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Salamone</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption</article-title>
          <source>Pharmacology Biochemistry and Behavior</source>
          <year iso-8601-date="2001">2001</year>
          <volume>69</volume>
          <fpage>373</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="doi">10.1016/S0091-3057(01)00524-X</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-38">
        <label>Ortinski et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ortinski</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Vassoler</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Temporally dependent changes in cocaine-induced synaptic plasticity in the nucleus accumbens shell are reversed by D1-like dopamine receptor stimulation</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2012">2012</year>
          <volume>37</volume>
          <fpage>1671</fpage>
          <lpage>1682</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2012.12</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-39">
        <label>Pezze, Dalley &amp; Robbins (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pezze</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Dalley</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2007">2007</year>
          <volume>32</volume>
          <fpage>273</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.npp.1301073</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-40">
        <label>Radke &amp; Gewirtz (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radke</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gewirtz</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal</article-title>
          <source>Neuropsychopharmacology</source>
          <year iso-8601-date="2012">2012</year>
          <volume>37</volume>
          <fpage>2405</fpage>
          <lpage>2415</lpage>
          <pub-id pub-id-type="doi">10.1038/npp.2012.97</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-41">
        <label>Saito et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leslie</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Civelli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain</article-title>
          <source>Journal of Comparative Neurology</source>
          <year iso-8601-date="2001">2001</year>
          <volume>435</volume>
          <fpage>26</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1002/cne.1191</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-42">
        <label>Saunders &amp; Robinson (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saunders</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>The role of dopamine in the accumbens core in the expression of Pavlovian-conditioned responses</article-title>
          <source>European Journal of Neuroscience</source>
          <year iso-8601-date="2012">2012</year>
          <volume>36</volume>
          <fpage>2521</fpage>
          <lpage>2532</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08217.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-43">
        <label>Schmidt &amp; Pierce (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat</article-title>
          <source>Neuroscience</source>
          <year iso-8601-date="2006">2006</year>
          <volume>142</volume>
          <fpage>451</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.06.004</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-44">
        <label>Sears et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sears</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Narayanan</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Sharf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yeckel</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Laubach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aghajanian</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>DiLeone</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2010">2010</year>
          <volume>30</volume>
          <fpage>8263</fpage>
          <lpage>8273</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5858-09.2010</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-45">
        <label>Seif et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seif</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Makriyannis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kunos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bonci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hopf</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing</article-title>
          <source>Neuroscience</source>
          <year iso-8601-date="2011">2011</year>
          <volume>193</volume>
          <fpage>21</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.07.055</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-46">
        <label>Shin et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>ZH</given-names>
            </name>
            <name>
              <surname>Ikemoto</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle</article-title>
          <source>Psychopharmacology</source>
          <year iso-8601-date="2008">2008</year>
          <volume>198</volume>
          <fpage>261</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="doi">10.1007/s00213-008-1131-x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-47">
        <label>Shirayama &amp; Chaki (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shirayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chaki</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents</article-title>
          <source>Current Neuropharmacology</source>
          <year iso-8601-date="2006">2006</year>
          <volume>4</volume>
          <fpage>277</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="doi">10.2174/157015906778520773</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-48">
        <label>Svenningsson et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svenningsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nishi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fisone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Girault</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Nairn</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Greengard</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>DARPP-32: an integrator of neurotransmission</article-title>
          <source>Annual Reviews of Pharmacology Toxicology</source>
          <year iso-8601-date="2004">2004</year>
          <volume>44</volume>
          <fpage>269</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.44.101802.121415</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-49">
        <label>Swerdlow et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swerdlow</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Shoemaker</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bongiovanni</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Neary</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Tochen</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Saint Marie</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration</article-title>
          <source>Pharmacology Biochemistry and Behavior</source>
          <year iso-8601-date="2007">2007</year>
          <volume>87</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pbb.2007.03.014</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-50">
        <label>Tebano, Martire &amp; Popoli (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tebano</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Martire</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A(2A)-cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission</article-title>
          <source>Brain Research</source>
          <year iso-8601-date="2012">2012</year>
          <volume>1476</volume>
          <fpage>108</fpage>
          <lpage>118</lpage>
          <comment>epub ahead of print</comment>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2012.04.051</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-51">
        <label>Tyhon et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tyhon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lakaye</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Adamantidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tirelli</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Amphetamine- and cocaine-induced conditioned place preference and concomitant psychomotor sensitization in mice with genetically inactivated melanin-concentrating hormone MCH(1) receptor</article-title>
          <source>European Journal of Pharmacology</source>
          <year iso-8601-date="2008">2008</year>
          <volume>599</volume>
          <fpage>72</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejphar.2008.09.027</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-52">
        <label>Wang et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Dever</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Storey</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Bhansali</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eck</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Nitulescu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Weimer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bamford</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
          <article-title>Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core</article-title>
          <source>Journal of Physiology</source>
          <year iso-8601-date="2012">2012</year>
          <volume>590</volume>
          <fpage>3743</fpage>
          <lpage>3769</lpage>
          <comment>epub ahead of print</comment>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2012.235200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-53">
        <label>Weiner (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiner</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment</article-title>
          <source>Psychopharmacology</source>
          <year iso-8601-date="2003">2003</year>
          <volume>169</volume>
          <fpage>257</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="doi">10.1007/s00213-002-1313-x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-54">
        <label>Wise (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wise</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Dopamine and reward: the anhedonia hypothesis 30 years on</article-title>
          <source>Neurotoxicology Research</source>
          <year iso-8601-date="2008">2008</year>
          <volume>14</volume>
          <fpage>169</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="doi">10.1007/BF03033808</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-55">
        <label>Yun et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yun</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Wakabayashi</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Fields</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Nicola</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues</article-title>
          <source>Journal of Neuroscience</source>
          <year iso-8601-date="2004">2004</year>
          <volume>24</volume>
          <fpage>2923</fpage>
          <lpage>2933</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5282-03.2004</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
